FAST NEWS: InnoCare inches closer to profitability on strong sales gains
The latest: InnoCare Pharma Ltd. (9969.HK) announced Tuesday its first-quarter revenue jumped 59% year-over-year to 189 million yuan ($27.3 million), while its net loss narrowed 90% to 12.41 million yuan. Looking…
Recent Articles
RELATED ARTICLES
-
BRIEF: InnoCare revenue jumps 37% in 2024 on strong lymphoma drug sales
9969.HK 688428.SHG -
After 14 years of losses, Zhihu finds an answer to its profitability question
2390.HK ZH.US
-
Lopal steers back towards profitability after tough two years
2465.HK 603906.SHG
-
Cango gets crypto jolt back to revenue growth, profitability
CANG.US
-
BRIEF: InnoCare, KeyMed in antibody licensing agree with Prolium
9969.HK 688428.SHG
